OMC
PRVB

Old Mission Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Old Mission Capital’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,283
Closed -$41K – 1505
2022
Q2 		$41K Buy
+10,283
New +$48.7K ﹤0.01% 1249

Other funds holding PRVB

SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Old Mission Capital's PRVB Position: Q3 2022 in Review

Old Mission Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q3 2022, closing a stake of 10,283 shares — an estimated $41K sold.

Old Mission Capital first reported a position in PRVB in Q2 2022 and held it in 1 quarter. The position peaked at $41K in Q2 2022. 112 funds tracked by Wall St. Rank hold PRVB as of Q3 2022.

  • Old Mission Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Old Mission Capital sold 10,283 Provention Bio, Inc. Common Stock shares in Q3 2022, an estimated $41K.
  • Old Mission Capital first reported a position in Provention Bio, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Old Mission Capital's Provention Bio, Inc. Common Stock position peaked at $41K in Q2 2022.
  • 112 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q3 2022.

Based on Old Mission Capital's 13F filing for Q3 2022, filed 14 Nov 2022.